New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study.
Côté
I
I
Nephrology Service, L'Hôtel-Dieu de Québec Hospital of the CHUQ, Canada.
Deschêsnes
L
L
de Cotret
P R
PR
Lachance
J G
JG
Noël
R
R
Isenring
P
P
Houde
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016030:Kidney Transplantation; D007962:Leukocytes / Q000821:virology; D008297:Male; D008875:Middle Aged; D010750:Phosphoproteins / Q000097:blood; D011183:Postoperative Complications / Q000097:blood / Q000453:epidemiology / Q000821:virology*; D012008:Recurrence; D012044:Regression Analysis; D012189:Retrospective Studies; D014763:Viral Matrix Proteins / Q000097:blood
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa